Unidad de Nefrología, Hospital General de Niños Pedro de Elizalde, Ciudad Autónoma de Buenos Aires, Argentina.
Arch Argent Pediatr. 2021 Dec;119(6):414-420. doi: 10.5546/aap.2021.eng.414.
Renal involvement among pediatric patients with coronavirus disease 2019 (COVID-19) ranges between 10% and 80%. Given the limited information about its prognosis, the objective of this study was to describe the short-term course of patients in whom renal involvement was detected during hospitalization due to COVID-19. This was an observational, cross-sectional study in patients aged 1 month to 18 years who had COVID-19 and renal involvement. Those with a known kidney disease were excluded. A total of 27 patients with renal involvement were identified; 14 of them were followed-up to study their disease course for 3 months after diagnosis. All of the patients had achieved normal plasma creatinine levels during hospitalization and, at the time of outpatient follow-up, which took place 145 days (92-193) later, all had normal blood pressure and urinary values, except for 1 patient who continued with microscopic hematuria. Course was favorable; in most patients, renal involvement had fully resolved.
在感染 2019 冠状病毒病（COVID-19）的儿科患者中，肾脏受累的比例在 10%至 80%之间。鉴于有关其预后的信息有限，本研究的目的是描述在因 COVID-19 住院期间发现肾脏受累的患者的短期病程。这是一项对年龄在 1 个月至 18 岁之间、患有 COVID-19 合并肾脏受累的患者进行的观察性、横断面研究。排除已知患有肾脏疾病的患者。共发现 27 例有肾脏受累的患者，其中 14 例在诊断后进行了 3 个月的随访以研究其疾病过程。所有患者在住院期间均达到正常的血浆肌酐水平，在门诊随访时（时间为 145 天[92-193]后），除 1 例患者仍有镜下血尿外，所有患者的血压和尿液值均正常。病程良好，大多数患者的肾脏受累完全缓解。
